Holland Foundation Expands Vision Restoration Network with New Partnership

Holland Foundation for Sight Restoration Partners with Illinois Eye and Ear Infirmary

The Holland Foundation for Sight Restoration has announced an exciting new partnership with the Illinois Eye and Ear Infirmary at the University of Illinois Chicago (UIC). This collaboration marks a significant step in addressing the critical unmet medical needs of patients suffering from blinding Severe Ocular Surface Disease (OSD). By establishing an additional Center of Excellence, this partnership strengthens the foundation's national network, expanding its capabilities to bring transformative vision restoration to a broader patient population.

Expanding Access to Treatment

The new center at UIC expands the foundation's reach to five Centers of Excellence, joining prestigious institutions such as Cincinnati Eye Institute, University of California Irvine, Virginia Eye Consultants in Norfolk, and Mass Eye and Ear in Boston. Each center is spearheaded by eminent corneal specialists who are dedicated to delivering advanced care in managing severe ocular surface diseases. This collective effort follows Dr. Holland's established protocols for treatment and exemplifies the ongoing commitment to providing patients with successful outcomes.

Dr. Ali R. Djalilian, a prominent figure in ophthalmology, will lead the newly established Center of Excellence at UIC. His expertise in managing severe corneal and ocular surface diseases, including limbal stem cell deficiency and transplantation, will be pivotal in this new collaboration. "We are honored to partner with the Holland Foundation to establish a Center of Excellence at the Illinois Eye and Ear Infirmary at the University of Illinois Chicago," Dr. Djalilian stated. "This partnership facilitates enhanced access to specialized care and enables us to deliver sight-restoring treatment to a greater number of patients grappling with severe ocular surface disease."

The Impact of the Cincinnati Protocol

At the forefront of the Holland Foundation's mission is The Cincinnati Protocol™, a groundbreaking procedure developed by Edward J. Holland, M.D. This protocol is designed to address the intricate challenges faced by patients suffering from severe OSD. By providing training to ophthalmologists worldwide and establishing a framework for the execution of this protocol, the foundation empowers medical professionals to offer effective and life-changing treatments to their patients.

The Cincinnati Protocol operates on the premise of coordinated teamwork among various specialties, including glaucoma, retina, oculoplastics, and nephrology. This multifaceted approach ensures that patients receive thorough management throughout their treatment journey, maximizing the potential for successful corneal transplants.

Light After Darkness Campaign

To further aid its mission, the Holland Foundation has launched the "Light After Darkness" campaign. This ambitious five-year initiative aims to raise $5 million in support of patients confronting corneal blindness due to Severe OSD. The campaign’s goals include enhancing access to specialized surgical care, advancing research, and fostering innovation within the field of ophthalmology. Philanthropic contributions from individuals and organizations will play a crucial role in empowering surgeons and driving transformative care for those in need.

The Holland Foundation for Sight Restoration is proud to be the only organization of its kind globally, specifically aimed at addressing the profound needs of those afflicted by Severe OSD. Co-founded by Robert J. Dempsey and Dr. Holland, the foundation remains dedicated to elevating standards of care for patients with ocular surface diseases. By supporting education for the implementation of The Cincinnati Protocol and establishing Centers of Excellence, the foundation strives to make substantial progress in combating corneal blindness on a worldwide scale.

In summary, the partnership between the Holland Foundation and the Illinois Eye and Ear Infirmary signifies a new hope for individuals with severe ocular surface diseases. As this initiative unfolds, it is expected to create a ripple effect of positive change, offering life-altering assistance to countless patients across the nation. Together, this collaboration stands on the frontier of innovation in ophthalmology, committed to restoring vision and transforming lives for the better.